aluates Reports

$ 0.0

Automative

Global Rotavirus Infection Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-14Q13812

Global Rotavirus Infection Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Rotavirus Infection Therapeutics Market Research Report 2025

Code: QYRE-Auto-14Q13812

Report

September 2025

Pages:69

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Rotavirus Infection Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rotavirus Infection Therapeutics Market

The global market for Rotavirus Infection Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Rotavirus (RV) is a double-stranded ribonucleic acid virus, which belongs to the reovirus family. It is the single leading cause of diarrhea in infants and young children, and almost every child in the world around the age of five has been infected with rotavirus at least once.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Rotavirus Infection Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rotavirus Infection Therapeutics.

The Rotavirus Infection Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rotavirus Infection Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rotavirus Infection Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Rotavirus Infection Therapeutics Market Report

Report Metric	Details
Report Name	Rotavirus Infection Therapeutics Market
CAGR	5%
Segment by Type	Oral Drug Injiectable Drug
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Bharat Biotech, Curevac, Ology Bioservices, BioKangtai
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rotavirus Infection Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rotavirus Infection Therapeutics Market report?

Ans: The main players in the Rotavirus Infection Therapeutics Market are GlaxoSmithKline, Bharat Biotech, Curevac, Ology Bioservices, BioKangtai

What are the Application segmentation covered in the Rotavirus Infection Therapeutics Market report?

Ans: The Applications covered in the Rotavirus Infection Therapeutics Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Rotavirus Infection Therapeutics Market report?

Ans: The Types covered in the Rotavirus Infection Therapeutics Market report are Oral Drug, Injiectable Drug

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Rotavirus Infection Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral Drug

1.2.3 Injiectable Drug

1.3 Market by Application

1.3.1 Global Rotavirus Infection Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Rotavirus Infection Therapeutics Market Perspective (2020-2031)

2.2 Global Rotavirus Infection Therapeutics Growth Trends by Region

2.2.1 Global Rotavirus Infection Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Rotavirus Infection Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Rotavirus Infection Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Rotavirus Infection Therapeutics Market Dynamics

2.3.1 Rotavirus Infection Therapeutics Industry Trends

2.3.2 Rotavirus Infection Therapeutics Market Drivers

2.3.3 Rotavirus Infection Therapeutics Market Challenges

2.3.4 Rotavirus Infection Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Rotavirus Infection Therapeutics Players by Revenue

3.1.1 Global Top Rotavirus Infection Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Rotavirus Infection Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Rotavirus Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Rotavirus Infection Therapeutics Revenue

3.4 Global Rotavirus Infection Therapeutics Market Concentration Ratio

3.4.1 Global Rotavirus Infection Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Rotavirus Infection Therapeutics Revenue in 2024

3.5 Global Key Players of Rotavirus Infection Therapeutics Head office and Area Served

3.6 Global Key Players of Rotavirus Infection Therapeutics, Product and Application

3.7 Global Key Players of Rotavirus Infection Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Rotavirus Infection Therapeutics Breakdown Data by Type

4.1 Global Rotavirus Infection Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Rotavirus Infection Therapeutics Forecasted Market Size by Type (2026-2031)

5 Rotavirus Infection Therapeutics Breakdown Data by Application

5.1 Global Rotavirus Infection Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Rotavirus Infection Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Rotavirus Infection Therapeutics Market Size (2020-2031)

6.2 North America Rotavirus Infection Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Rotavirus Infection Therapeutics Market Size by Country (2020-2025)

6.4 North America Rotavirus Infection Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Rotavirus Infection Therapeutics Market Size (2020-2031)

7.2 Europe Rotavirus Infection Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Rotavirus Infection Therapeutics Market Size by Country (2020-2025)

7.4 Europe Rotavirus Infection Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Rotavirus Infection Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Rotavirus Infection Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Rotavirus Infection Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Rotavirus Infection Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Rotavirus Infection Therapeutics Market Size (2020-2031)

9.2 Latin America Rotavirus Infection Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Rotavirus Infection Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Rotavirus Infection Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Rotavirus Infection Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Rotavirus Infection Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Details

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Rotavirus Infection Therapeutics Introduction

11.1.4 GlaxoSmithKline Revenue in Rotavirus Infection Therapeutics Business (2020-2025)

11.1.5 GlaxoSmithKline Recent Development

11.2 Bharat Biotech

11.2.1 Bharat Biotech Company Details

11.2.2 Bharat Biotech Business Overview

11.2.3 Bharat Biotech Rotavirus Infection Therapeutics Introduction

11.2.4 Bharat Biotech Revenue in Rotavirus Infection Therapeutics Business (2020-2025)

11.2.5 Bharat Biotech Recent Development

11.3 Curevac

11.3.1 Curevac Company Details

11.3.2 Curevac Business Overview

11.3.3 Curevac Rotavirus Infection Therapeutics Introduction

11.3.4 Curevac Revenue in Rotavirus Infection Therapeutics Business (2020-2025)

11.3.5 Curevac Recent Development

11.4 Ology Bioservices

11.4.1 Ology Bioservices Company Details

11.4.2 Ology Bioservices Business Overview

11.4.3 Ology Bioservices Rotavirus Infection Therapeutics Introduction

11.4.4 Ology Bioservices Revenue in Rotavirus Infection Therapeutics Business (2020-2025)

11.4.5 Ology Bioservices Recent Development

11.5 BioKangtai

11.5.1 BioKangtai Company Details

11.5.2 BioKangtai Business Overview

11.5.3 BioKangtai Rotavirus Infection Therapeutics Introduction

11.5.4 BioKangtai Revenue in Rotavirus Infection Therapeutics Business (2020-2025)

11.5.5 BioKangtai Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Rotavirus Infection Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral Drug

Table 3. Key Players of Injiectable Drug

Table 4. Global Rotavirus Infection Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Rotavirus Infection Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Rotavirus Infection Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Rotavirus Infection Therapeutics Market Share by Region (2020-2025)

Table 8. Global Rotavirus Infection Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Rotavirus Infection Therapeutics Market Share by Region (2026-2031)

Table 10. Rotavirus Infection Therapeutics Market Trends

Table 11. Rotavirus Infection Therapeutics Market Drivers

Table 12. Rotavirus Infection Therapeutics Market Challenges

Table 13. Rotavirus Infection Therapeutics Market Restraints

Table 14. Global Rotavirus Infection Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Rotavirus Infection Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Rotavirus Infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Infection Therapeutics as of 2024)

Table 17. Ranking of Global Top Rotavirus Infection Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Rotavirus Infection Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Rotavirus Infection Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Rotavirus Infection Therapeutics, Product and Application

Table 21. Global Key Players of Rotavirus Infection Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Rotavirus Infection Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Rotavirus Infection Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Rotavirus Infection Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Rotavirus Infection Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Rotavirus Infection Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Rotavirus Infection Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Rotavirus Infection Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Rotavirus Infection Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Rotavirus Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Rotavirus Infection Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Rotavirus Infection Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Rotavirus Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Rotavirus Infection Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Rotavirus Infection Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Rotavirus Infection Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Rotavirus Infection Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Rotavirus Infection Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Rotavirus Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Rotavirus Infection Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Rotavirus Infection Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Rotavirus Infection Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Rotavirus Infection Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. GlaxoSmithKline Company Details

Table 47. GlaxoSmithKline Business Overview

Table 48. GlaxoSmithKline Rotavirus Infection Therapeutics Product

Table 49. GlaxoSmithKline Revenue in Rotavirus Infection Therapeutics Business (2020-2025) & (US$ Million)

Table 50. GlaxoSmithKline Recent Development

Table 51. Bharat Biotech Company Details

Table 52. Bharat Biotech Business Overview

Table 53. Bharat Biotech Rotavirus Infection Therapeutics Product

Table 54. Bharat Biotech Revenue in Rotavirus Infection Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Bharat Biotech Recent Development

Table 56. Curevac Company Details

Table 57. Curevac Business Overview

Table 58. Curevac Rotavirus Infection Therapeutics Product

Table 59. Curevac Revenue in Rotavirus Infection Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Curevac Recent Development

Table 61. Ology Bioservices Company Details

Table 62. Ology Bioservices Business Overview

Table 63. Ology Bioservices Rotavirus Infection Therapeutics Product

Table 64. Ology Bioservices Revenue in Rotavirus Infection Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Ology Bioservices Recent Development

Table 66. BioKangtai Company Details

Table 67. BioKangtai Business Overview

Table 68. BioKangtai Rotavirus Infection Therapeutics Product

Table 69. BioKangtai Revenue in Rotavirus Infection Therapeutics Business (2020-2025) & (US$ Million)

Table 70. BioKangtai Recent Development

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

Table 74. Authors List of This Report

List of Figures

Figure 1. Rotavirus Infection Therapeutics Picture

Figure 2. Global Rotavirus Infection Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Rotavirus Infection Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Oral Drug Features

Figure 5. Injiectable Drug Features

Figure 6. Global Rotavirus Infection Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Rotavirus Infection Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Online Pharmacies Case Studies

Figure 11. Rotavirus Infection Therapeutics Report Years Considered

Figure 12. Global Rotavirus Infection Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Rotavirus Infection Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Rotavirus Infection Therapeutics Market Share by Region: 2024 VS 2031

Figure 15. Global Rotavirus Infection Therapeutics Market Share by Players in 2024

Figure 16. Global Top Rotavirus Infection Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Infection Therapeutics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Rotavirus Infection Therapeutics Revenue in 2024

Figure 18. North America Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Rotavirus Infection Therapeutics Market Share by Country (2020-2031)

Figure 20. United States Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Rotavirus Infection Therapeutics Market Share by Country (2020-2031)

Figure 24. Germany Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Rotavirus Infection Therapeutics Market Share by Region (2020-2031)

Figure 32. China Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Rotavirus Infection Therapeutics Market Share by Country (2020-2031)

Figure 40. Mexico Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Rotavirus Infection Therapeutics Market Share by Country (2020-2031)

Figure 44. Turkey Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Rotavirus Infection Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. GlaxoSmithKline Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2020-2025)

Figure 48. Bharat Biotech Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2020-2025)

Figure 49. Curevac Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2020-2025)

Figure 50. Ology Bioservices Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2020-2025)

Figure 51. BioKangtai Revenue Growth Rate in Rotavirus Infection Therapeutics Business (2020-2025)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bovine Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rotavirus Vaccine Market Research Report 2024

Global Veterinary Infectious Diseases Therapeutics Market Insights Forecast to 2030

Global Gram Negative Bacterial Infection Therapeutics Market Research Report 2024

Global Diarrhea Drug Market Research Report 2024

Respiratory Virus Infection Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intestinal Anti infective Drugs Market Research Report 2024

Global Enterobacteriaceae Infection Drug Market Research Report 2024

Global Chlamydia Infection Therapeutics Market Research Report 2024

Global Anti Infective Therapy Market Research Report 2024

Global Antidiarrheal Microorganisms Market Research Report 2024

Global Infectious Disease Clinical Trials Market Research Report 2025

Oral Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Norovirus Vaccine Market Research Report 2024

Global Antiviral Microbial Drugs Market Research Report 2024

Global Respiratory Syncytial Virus Therapeutic Drugs Market Research Report 2024

Global Urinary Tract Infection Therapeutics Market Research Report 2025

Infectious Enteritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Live Attenuated Rotavirus Vaccine Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions